Since its inception, KYOWA HAKKO U.S.A., INC. has driven transformative advancements in health and wellness, harnessing world-class biotechnology as part of Kirin Holdings’ Health Science domain. The Japanese word "Hakko," meaning fermentation, reflects our core expertise, fueling the creation of premium, science-backed bioactive ingredients like Cognizin® Citicoline and Setria® Glutathione. Rooted in over 75 years of biotech innovation and Kirin’s century-long fermentation legacy, we deliver sustainable, high-impact solutions for the nutraceutical, pharmaceutical, and wellness industries, advancing Kirin’s mission to enhance quality of life and address societal health needs.
Our ingredients are backed by decades of rigorous research, conducted by Kyowa’s expert scientists and trusted global partners. Published in peer-reviewed journals, our findings validate the efficacy of our bioactive solutions in supporting health and holistic well-being. Kyowa’s research and development team relentlessly pursues new frontiers, ensuring our specialty materials uphold Kirin’s standard of biotechnological excellence and shape a healthier, more sustainable future.
View specific research information for these products on their own website: